Drug testing in biological samples vs. maternal surveys for the detection of substance use during whole pregnancy
Drug testing in biological samples vs. maternal surveys for the detection of substance use during whole pregnancy
复制标题
DOI:
10.1080/10550887.2020.1831137
复制
发表时间:
2020-10-13
影响因子:
2.3
通讯作者:
Fernandez-Lorenzo, Jose Ramon
中科院分区:
文献类型:
--
作者:
Gonzalez-Colmenero, Eva;Concheiro-Guisan, Ana;Fernandez-Lorenzo, Jose Ramon
Background Early diagnosis of nicotine, ethanol and drug use during pregnancy is critical in order to provide adequate care. Current screening procedures show limitations in terms of reliability and short windows of detection. Objectives To investigate the prevalence and identify biomarkers of substance use and changes in substance use during pregnancy. To compare drug testing results in different types of biological samples (maternal hair, meconium, placenta, umbilical-cord) with self-reported data. Participants and setting Prospective cohort study using data from pregnant women and their newborns. Methods Biological matrices were collected at birth and analyzed by liquid chromatography tandem mass spectrometry. A paper survey was provided to determine substance use habits. Results 867 mother-newborn pairs were included. According to the analysis of biological samples, 29.1% cases were positive for one or more substances (13.6% nicotine, 8.4% ethanol, 8.3% cocaine, 6.4% cannabis, 5.7% opioids). The profile of the substance-using mother was a single woman,